| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/2005 | US6858722 Oligomer phosphoramidite compositions and processes for synthesizing the same |
| 02/22/2005 | US6858652 Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858650 Stable salts of novel derivatives of 3,3-diphenylpropylamines |
| 02/22/2005 | US6858649 Contacting the cell having the human serotonin receptor subtype 5-HT1A with a quantity of a serotonergic agent possessing 5- HT1A agonist activity sufficient for potentiating the serotonin response within cell |
| 02/22/2005 | US6858647 Administering retinoid such as, 6-(3-(1-Adamantyl)-4-methoxy-5-hydroxyphenyl)-2-naphthoic acid benzoic acid for therapy of and prophylaxis of bacterial infection |
| 02/22/2005 | US6858646 Administering an antioxidative composition comprising pyruvate, at least one antioxidant and at least one lipid. |
| 02/22/2005 | US6858645 Prevention or the treatment of CNS disorders and related medical disturbances comprising effective amount of the salt according dissolving (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5 -carboxamide in an appropriate |
| 02/22/2005 | US6858644 Use as anti-tumor agents; examples of solvents are N-methyl-2-pyrrolidone and acetonitrile |
| 02/22/2005 | US6858643 Crystalline forms of Fluvastatin sodium |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858641 Substituted indolinones |
| 02/22/2005 | US6858639 3-Arylphenyl sulfide derivative and insecticide and miticide |
| 02/22/2005 | US6858638 Substituted indazoles, compositions containing them, method of production and use |
| 02/22/2005 | US6858637 Treating rheumatoid arthritis, psoriasis, cardiovascular disease, reperfusion injury, and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide |
| 02/22/2005 | US6858636 Angiotensin II antagonists for treating cardiovascular disorders, hypertension, congestive heart failure and glaucoma. |
| 02/22/2005 | US6858633 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 02/22/2005 | US6858632 Derivatives of isosorbide mononitrate and its use as vasodilating agents with reduced tolerance |
| 02/22/2005 | US6858631 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl |
| 02/22/2005 | US6858629 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858625 Quinolinecarboxylic acid derivative or salts thereof |
| 02/22/2005 | US6858624 Comprises 5,8,14-triazatetracyclo(10.3.1.0.0)-hexadeca-2(11),3,5,7,9-penaene groups; for reducing drug addiction, treating Alzheimer's/Parkinson's diseases, and other nervous system disorders |
| 02/22/2005 | US6858622 Cycloalkano-indole and -azaindole derivatives |
| 02/22/2005 | US6858621 Mbreast and prostate anticancer agents; viricides; alopecia |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858619 Fused heterocyclic compounds |
| 02/22/2005 | US6858618 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 02/22/2005 | US6858615 Phenyl guanidine sodium channel blockers |
| 02/22/2005 | US6858614 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for treating chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 02/22/2005 | US6858613 Central nervous system disorders |
| 02/22/2005 | US6858612 Use of tetrahydropteridine derivatives as no synthase inhibitors |
| 02/22/2005 | US6858610 Autoimmune disease; antiinflammatory agents |
| 02/22/2005 | US6858609 Substituted diamino-1,3,5-triazine derivatives |
| 02/22/2005 | US6858608 Chemical derivatives and their application as antitelomerase agents |
| 02/22/2005 | US6858607 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/22/2005 | US6858606 Nitrogen compounds such as 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one, used to control interleukin production; antiinflammatory agents |
| 02/22/2005 | US6858604 Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | US6858601 Parasiticidal formulation for animals |
| 02/22/2005 | US6858598 Administering N-hydroxy-2,2-dimethyl-4-((4-(4-pyridinyloxy)phenyl)sulfonyl)-3 -thiomorpholinecarboxamide and an antineoplastic agent selected from irinotecan and topotecan and a combination thereof for therapy of lung cancer |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/22/2005 | US6858596 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 02/22/2005 | US6858595 Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| 02/22/2005 | US6858594 Compounds and methods for treating urinary incontinence |
| 02/22/2005 | US6858593 Composition in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in the crystalline composition is of space group P212121 having unit cell dimensions of about 7. 6+-0.6 Angstrom , 12.7+-0.7 Angstrom , |
| 02/22/2005 | US6858592 Prevent absorption of fats |
| 02/22/2005 | US6858589 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 02/22/2005 | US6858588 Nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from moringa oleifera |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/22/2005 | US6858431 An osteoinductive soluble factor induced by the expression of human mineralization protein. |
| 02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/22/2005 | US6858416 Human desaturase gene and uses thereof |
| 02/22/2005 | US6858411 Recombinant nucleic acids that encode epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells to produce epothilone derivatives/polyketides; used as cancer drugs, fungicides and immunosuppressants |
| 02/22/2005 | US6858390 Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| 02/22/2005 | US6858383 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 02/22/2005 | US6858307 Method for the production of low defect density silicon |
| 02/22/2005 | US6858236 Nutriceutical and drug compositions containing a plant extract or concentrate from the genus Lycopersicon (tomato); bone disorders, e.g., Paget's disease, tumor-induced bone disease or particularly osteoporosis; metabolic disorders |
| 02/22/2005 | US6858235 Antioxidant composition and method of preparation thereof |
| 02/22/2005 | US6858233 Simmondsin processing methods and products |
| 02/22/2005 | US6858232 Topical transdermal treatments |
| 02/22/2005 | US6858228 Compression of drug and adjuvant |
| 02/22/2005 | US6858227 Useful in solubilizing lipophilic and relatively water-insoluble compounds; cosmetics, drugs |
| 02/22/2005 | US6858225 A mixture of lipids containing a protonatable or deprotonatable lipid, such as polyoxyethylene glycol or polyamide oligomer modified lipid, or amino lipid is combined with a buffered aqueous solution of a charged drug |
| 02/22/2005 | US6858223 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS) |
| 02/22/2005 | US6858222 Fabrication of drug loaded biodegradable polymer fibers |
| 02/22/2005 | US6858219 Methods for sterilizing male mammals |
| 02/22/2005 | US6858216 Treatment of keratin fibers and skin. |
| 02/22/2005 | US6858203 Treating of hyperphosphatemia by ingesting a ion exchanging resin comprising an allyl addition polymer having an amine salt or quaternary amine functional group; side effect reduction |
| 02/22/2005 | US6858199 High efficient delivery of a large therapeutic mass aerosol |
| 02/22/2005 | US6858166 Enteric coatings for drugs; sustained rlease |
| 02/22/2005 | US6858018 Iontophoretic devices |
| 02/22/2005 | CA2478783A1 Compound to prevent and/or fight the breakdown of collagen constructs when exposed to natural sunlight |
| 02/22/2005 | CA2438438A1 Controlled release granules comprising porous silica core |
| 02/22/2005 | CA2310778C Intermediates and methods useful in the semisynthesis of paclitaxel and analogs |
| 02/22/2005 | CA2236256C A pharmaceutical composition for the treatment of autoimmune diseases |
| 02/22/2005 | CA2233489C New [(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics |
| 02/22/2005 | CA2220434C The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 02/22/2005 | CA2218493C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/22/2005 | CA2106423C Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3 |
| 02/22/2005 | CA2093078C 2-substituted tertiary carbinol derivatives of 1,5-iminosugars |
| 02/22/2005 | CA2093077C 2- and 3-amino and azido derivatives of 1,5-iminosugars |
| 02/21/2005 | CA2478216A1 Stabilized compositions containing an oxygen-labile active agent |
| 02/21/2005 | CA2477901A1 Cyanoacrylate compositions containing anti-microbial agent |
| 02/17/2005 | WO2005015159A2 Methods for modulating a drug-related effect or behavior |
| 02/17/2005 | WO2005014856A1 Sensitivity test to predict efficacy of anti-cancer therapies |
| 02/17/2005 | WO2005014818A1 Gene overexpressed in cancer |
| 02/17/2005 | WO2005014810A1 Efficient process for producing dumbbell dna |
| 02/17/2005 | WO2005014809A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 02/17/2005 | WO2005014783A2 Reducing axon degeneration with proteasome inhibitors |
| 02/17/2005 | WO2005014776A2 Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 02/17/2005 | WO2005014657A1 Method of processing seaweed |
| 02/17/2005 | WO2005014656A1 Polysaccharides derivatives with high antithrombotic activity in plasma |
| 02/17/2005 | WO2005014614A1 Steroid derivatives and use thereof as medicaments |
| 02/17/2005 | WO2005014611A1 The artificial cpg single strand deoxidation oligonucleotide and its antiviral uses |
| 02/17/2005 | WO2005014609A2 Method of producing a highly stereoregular phosphorus atom-modified nucleotide analogue |
| 02/17/2005 | WO2005014600A1 Antagonists of mcp-1 function and methods of use thereof |